SoftOx Solutions AS is a biotechnology company specializing in developing infection control and wound care solutions. With a strong focus on addressing antimicrobial resistance, which is a growing concern in global health, SoftOx develops innovative products designed to combat bacterial infections without promoting resistance. Their key offerings span across the healthcare and veterinary sectors, including topical treatments and disinfectants that leverage proprietary non-alcoholic biocidal technology. The company's solutions are particularly significant in settings requiring high hygiene standards, such as hospitals, clinics, and animal husbandry. By contributing to the control of infections and reducing the dependence on traditional antibiotics, SoftOx Solutions AS plays a critical role in public health and safety. Based in Norway, SoftOx is actively involved in advancing research and development in biotechnology, aligning with global efforts to address crucial health challenges.
Markedsdata leveret af TwelveData og Morningstar